Team L&M Cervical cancer, the fourth most common cancer among women globally, remains a critical yet often overlooked health issue. It accounts for approximately 7.5 per cent of all female cancer deaths worldwide, with a significant burden in low- and middle-income countries. In India, it is the second most common cancer in women, contributing to […]Read More
Tags : cervical cancer
Team L&M Healthcare platform Karkinos Healthcare has introduced CerviRaksha, a first-of-its-kind clinically-validated HPV test, which is pre-qualified by the World Health Organisation (WHO) and approved by the Food and Drug Administration (FDA), USA and was also granted the CE mark meeting European Health Standards. “Among all the cancers, Cervical Cancer is completely curable, only if […]Read More